Evaluate the Efficacy and Safety of Adebrelimab Combined With Chemotherapy With or Without Radiotherapy as Neoadjuvant Treatment for HER2-Negative Locally Advanced Breast Cancer

NCT06908668 · clinicaltrials.gov ↗

PHASE2

Phase

NOT_YET_RECRUITING

Status

170

Enrollment

OTHER

Sponsor class

Conditions

HER2-Negative Locally Advanced Breast Cancer

Interventions

DRUG: Neoadjuvant Chemotherapy Combined with Immunotherapy and Radiotherapy
DRUG: Neoadjuvant Chemotherapy Combined with Immunotherapy

Sponsor

Cancer Institute and Hospital, Chinese Academy of Medical Sciences